Page 21 - AWA-41-No.1 issue
P. 21

DAIRY FARMING


         liBond® improved colostrum yield and   ZIVO Bioscience  Active Ingredients in the Battle
         increased energy corrected milk (ECM)
         in the first 15 weeks of lactation, without            Against Avian Influenza
         affecting dry matter intake (DMI) post-  ivo Bioscience, Inc. a pioneering
         partum. Cows that received hydroxy   Zbiotech/agtech R&D company dedi-
         trace minerals also performed better in   cated to developing therapeutic, medici-
         terms of disease incidence, which led   nal and nutritional product candidates
         to lower culling rates and better fertil-  derived from proprietary algal cultures,
         ity (more cows pregnant at 305 days in   reports favorable results from a study con-
         milk DIM)), compared to the cows that   ducted in collaboration with the Universi-
                                             ty of Delaware that evaluated the potential
         received sulphate-based trace minerals.
                                             of ZIVO’s proprietary active ingredients to
          Using Selko® IntelliBond® hydroxy   reduce the transmission of Low Pathoge-  ing that an optimal product configuration
         trace minerals (Zn, Cu and Mn) also in-  nicity Avian Influenza (LPAI) virus among   could provide more comprehensive pro-
         fluence methane emissions, one of the   poultry.                       tection. The study’s positive outcomes jus-
                                                                                tify further research and product develop-
         most important parameters in dairy sus-  Key findings of statistical significance   ment, supporting the potential of ZIVO’s
         tainability. This study presented at Dairy-  from the study include:   pipeline to address both LPAIV infections
         NutriVision showed that hydroxy trace   • A reduction in viral titers (viral shed-  as well as a broad spectrum of other viral
         minerals improved in vitro fermentation   ding) in infected birds receiving ZIVO’s   challenges faced by the poultry industry.
         parameters of apparent Organic Matter   products compared with untreated infect-
         Disappearance (aOMD) and Apparent   ed controls.                        “We are highly encouraged by the out-
         Microbial Biomass Production (aMBP;                                    comes of this study,” said John B. Payne,
                                                                                Chairman and CEO of ZIVO Bioscience.
                                              • A delay in transmission of LPAI when
         proxy for milk production) compared   healthy birds were exposed to infected   “The University of Delaware’s findings
         to other trace mineral sources. This im-  birds,  suggesting  a  slower  and  less  ag-  provide compelling evidence that our
         provement in rumen fermentation in the   gressive spread of disease.   feed ingredients could be valuable tools
         hydroxy trace mineral group led to a                                   in mitigating the risk of avian influenza
         decreased release of methane per unit   The two-part controlled study evaluated   outbreaks  without  the  limitations  asso-
         of aOMD. Earlier, an independent verifi-  the efficacy of ZIVO’s proprietary active   ciated with vaccines. Reducing disease
                                             ingredients, previously shown to be effi-
         cation of an LCA evaluating the ability of   cacious for mitigating the effects of coc-  transmission can positively impact both
         Selko® IntelliBond® to reduce the cow’s   cidiosis in broiler chickens, against LPAI.  animal welfare and the operations of pro-
         carbon footprint showed that it can re-                                ducers.  These  study  results  represent  a
         duce the cow’s carbon footprint by up to   In the first part of the study, infected   significant milestone in our efforts to de-
         2%, compared to sulphate-based trace   birds receiving a mixture of ZIVO’s pro-  liver science-driven, sustainable solutions
                                             prietary  active  ingredients  showed  an
         minerals.                                                              to address serious challenges facing the
                                             early significant decrease in viral titers   global poultry industry.”
          Conclusion                         compared  with  untreated,  infected  con-
                                             trols, thereby reducing amount of detect-  “This study sponsored by ZIVO Biosci-
          For successful dairy production, it is im-  able virus that was shed. At the end of the   ence enabled us to evaluate novel inter-
         portant to ensure the right nutrients and/  study, although not significant in nature, a   ventions to provide immune support for
         or additives are present at the right time   numerical decrease in virus was noted in   poultry,” said Brian Ladman, Ph.D., Princi-
         to support optimised productivity, health   birds receiving ZIVO’s product. In the sec-  pal Investigator at the University of Dela-
         and well-being, cost-effectiveness and   ond part, healthy chickens were housed   ware’s Department of Animal and Food
         environmental sustainability. Supple-  with infected birds, replicating a real-  Sciences. “The findings demonstrate that
         mentation with a quality source of trace   world, high-risk environment for disease   further investigation into ZIVO’s active
         minerals is required to keep dairy cows   transmission. Compared to an untreated   ingredients to safeguard poultry flocks
                                             control group, birds that received ZIVO’s
         healthy and productive. An increasing   proprietary active ingredients that were   against viral outbreaks is warranted. I
         amount of research is  now available  to   housed with infected birds experienced   look forward to continuing to work with
                                                                                ZIVO to identify novel solutions to this
         allow  us  to  choose  the  most  effective   a  statistically  significant  delay  in  viral   critical public health issue.”
         source while fine-tuning recommenda-  detection. This observed delay suggests
         tions and feeding strategies.       that ZIVO’s products limit viral replication   “With these preliminary efficacy re-
                                             within a host.                     sults, we are now planning additional
          Selko and  Trouw Nutrition are at the                                 studies to further evaluate the benefits of
         forefront in dairy cow nutrition, providing   These favorable results indicate that   our products. We are at a critical point in
         cutting edge research and application of   ZIVO’s proprietary active ingredients rep-  our mission to find a viable treatment for
         its highly effective hydroxy trace miner-  resent potential preventative measures   avian influenza, and the need for an effec-
         als. At DairyNutriVision, some of these   for reducing the spread of LPAIV in com-  tive therapy grows every day,” said John
         recent insights were shared with a global   mercial poultry operations and enhancing   Payne. “We will continue towards com-
                                             overall flock health.
         audience, leading to better understand-                                mercialization of our coccidiosis treat-
         ing of trace mineral nutrition and the use   Multiple products were explored to iden-  ment while utilizing these preliminary re-
         of trace minerals, a crucial part in our   tify the most effective strategies against   sults to further our partnership dialogues.
         quest to building the sustainable dairy   LPAI. While some products were better at   I am confident that ZIVO can take the
         cow of the future.                  lowering the viral titer, others were more   next step toward evaluating this potential
                                             effective at slowing the spread, suggest-  breakthrough technology.”
                            Circle 25 on enquiry card                                              Circle 26 on enquiry card
                                                                                                      Vol. 41 No. 1   19
   16   17   18   19   20   21   22   23   24   25   26